Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION ...

Music therapy significantly improves sleep quality in adults aged 50 and above, showing a moderate-to-large effect compared ...

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack ...

The Mediterranean diet showed noninferiority and superiority in treating IBS vs. traditional dietary advice.The mechanism ...

During winter, people often move less, eat heavier meals, and gain weight or see blood-sugar spikes. Amla may help in this ...

Researchers performed a systematic review and meta-analysis to explore the therapeutic role and safety of low-dose naltrexone for treating fibromyalgia.

A new study links melatonin use with increased risk of heart disease, but does it really cause heart failure? Dr Yaranov explains what the study actually means.

New research linked long-term melatonin use with heart failure risk. However, more research is needed to validate the findings.

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic ...

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

"GC [gonococcal] AMR [antimicrobial resistance] is of concern worldwide, particularly resistance to third-generation cephalosporins and fluoroquinolones, and is considered a priority issue by the WHO ...

Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a Phase 2a, randomized, double-blind, placebo-controlled trial of setanaxib in patients ...